Over the last decades, the application of molecular biology techniques and methods tremendously improved our understanding of cellular responses of both tumor and normal cells and tissues to radiation as well as chemotherapy. Consequently and especially with respect to modern radiation oncology, mechanistic insights resulting from molecular radiation biology/oncology research have and still will provide tools to develop new strategies of individualized therapy and molecular targeting in modern radiation oncology to further improve tumor responses and reduce normal tissue reactions. Since 1998, cutting-edge results to these aspects are discussed during the Wolfsberg Meeting Series on Molecular Radiation Biology/Oncology.

Every second year, the Wolfsberg Meeting Series brings together basic and clinical scientists of the disciplines Molecular and Cell Biology, Tumor and Normal Tissue Biology, Radiobiology and Radiation Oncology to discuss the latest developments in the fields of basic and translational cancer research. These, most likely, will have tremendous impact on the development and/or optimization of treatment strategies in oncology and especially radiation oncology.

To promote translation of basic research results into clinical application, an intensified dialogue between basic and clinical scientists is important. To this aim, the structure and spirit of the Wolfsberg Meeting Series create and provide the informal atmosphere, which is necessary to discuss specific questions without time pressure usually encountered at bigger conferences. Thus, all basic and clinical researchers and, especially, young scientists are encouraged to discuss newest scientific approaches and results of importance for translational research in radiation biology/radiation oncology.